The article analyzes how AI testing is moving from experimental use to strategic QA governance, emphasizing the need for robust validation processes, multi‑layer verification, risk‑prediction metrics, and collaborative GenAI agents to turn speed gains into genuine quality improvements.
Using a dataset of 11,647 hepatocellular carcinoma patients, a French research team combined ensemble learning, SHAP explainability, UMAP dimensionality reduction and K‑medoids clustering to build an interpretable model that outperforms traditional scores in predicting three‑month wait‑list mortality and defines seven clinically distinct risk sub‑groups.
Researchers at Mount Sinai Icahn School of Medicine used gradient‑boosting trees on over one million electronic health records to build machine‑learning models for ten hereditary diseases, quantifying the penetrance of genetic variants and demonstrating how probabilistic risk scores can improve clinical interpretation and patient management.
Using a road freight accident prediction example, the article warns that interpreting predictive model explanations as causal effects can be misleading, explains when such models may answer causal questions, demonstrates SHAP analysis on an XGBoost model, and recommends causal inference tools like ecoml for reliable effect estimation.
The article analyzes the after‑sales process of international hotel bookings, defines key metrics such as defect rate and SPO, describes operational improvements, and presents a LightGBM‑based risk‑prediction model to reduce on‑site defects and enhance overall service efficiency.
